Castle Biosciences, Inc. Stock
Equities
CSTL
US14843C1053
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.86 USD | -1.00% | +5.41% | -7.97% |
Financials (USD)
Sales 2024 * | 238M | Sales 2025 * | 257M | Capitalization | 548M |
---|---|---|---|---|---|
Net income 2024 * | -61M | Net income 2025 * | -55M | EV / Sales 2024 * | 1.42 x |
Net cash position 2024 * | 210M | Net cash position 2025 * | 184M | EV / Sales 2025 * | 1.41 x |
P/E ratio 2024 * |
-8.86
x | P/E ratio 2025 * |
-10.2
x | Employees | 610 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.96% |
Latest transcript on Castle Biosciences, Inc.
1 day | -1.00% | ||
1 week | +5.41% | ||
Current month | -10.34% | ||
1 month | -2.02% | ||
3 months | +0.86% | ||
6 months | +50.23% | ||
Current year | -7.97% |
Managers | Title | Age | Since |
---|---|---|---|
Derek Maetzold
FOU | Founder | 62 | 07-08-31 |
Franklin Stokes
DFI | Director of Finance/CFO | 54 | 17-11-30 |
Johnson Clare
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Derek Maetzold
FOU | Founder | 62 | 07-08-31 |
Daniel Bradbury
CHM | Chairman | 62 | 12-08-31 |
G. Cole
BRD | Director/Board Member | 68 | 18-12-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.99% | 11 M€ | -6.03% | - | |
0.60% | 12 M€ | -.--% | - | |
0.06% | 0 M€ | 0.00% | - | |
0.05% | 0 M€ | 0.00% | - | |
0.02% | 237 M€ | +1.49% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 19.86 | -1.00% | 113,413 |
24-04-23 | 20.06 | +2.29% | 198,460 |
24-04-22 | 19.61 | +1.55% | 94,950 |
24-04-19 | 19.31 | +0.57% | 129,601 |
24-04-18 | 19.2 | +1.91% | 139,714 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.97% | 548M | |
-0.50% | 12.72B | |
-11.57% | 7.5B | |
+1.93% | 5.48B | |
+0.98% | 4.61B | |
+5.18% | 4.47B | |
-50.82% | 3.28B | |
+11.23% | 2.71B | |
-16.85% | 2.02B | |
-10.84% | 1.74B |
- Stock Market
- Equities
- CSTL Stock